Eschwege, Germany – The Molecular Biology group of MP Biomedicals having more than twenty years of experience in the research and development of sample preparation and nucleic acid purification solutions is pleased to announce the release of two new kits designed for the isolation of total RNA from animal and plant tissues, cultured cells and […]
Eschwege, Germany: – The Molecular Biology group of MP Biomedicals having more than twenty years of experience in the research and development of sample preparation and nucleic acid purification solutions is pleased to announce the release of two new kits designed for the isolation of total RNA from animal and plant tissues, cultured cells and bacteria […]
Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets London – KKR, a leading global investment firm, announced today the closing of its previously announced investment in Biosynth Carbosynth, an innovative life sciences reagents, custom synthesis and manufacturing services company, as well as Biosynth Carbosynth’s acquisition of vivitide, […]
Kun Zhang and Arnold Kriegstein to Join Scientific Advisory Board, Lending Critical Expertise in Cell Biology SANTA CLARA, Calif. — Rebus Biosystems Inc, (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, announced today that Arnold Kriegstein, M.D., PhD. and Kun Zhang, PhD., have been appointed […]
New funding to accelerate the scaling of operations and market introduction of its revolutionary “morpholomics” platform. MENLO PARK, Calif. — Deepcell, a life science company pioneering AI-powered single cell classification and isolation for basic and translational research, today announced that it has closed its $73 million Series B round of financing. The new funding will allow […]
New Chair brings extensive financial and life sciences experience with industry-leading companies SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced it has appointed Stuart Essig, PhD, as Chair of its Board of Directors. Dr. Essig is currently a Managing Partner of Prettybrook Partners and Chairman of the […]
MENLO PARK, Calif. — Gamma Biosciences, a global life sciences company formed by KKR to serve the advanced therapy market with best-in-class bioprocessing solutions, today announced that Kieran P. Murphy will join its Board of Directors as Executive Chairman. With a long track record of building leading businesses in biopharma and life sciences, Mr. Murphy […]
Relocation driven by increased demand for Vector Laboratories’ growing areas of focus, glycomics and proteomics Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in Newark, California, where it will relocate its corporate headquarters this year. The relocation is accompanied by the rebranding and launch of a new corporate […]
Financing demonstrates the value of Laminar Wash technology in accelerating and standardizing therapeutic research and development WOBURN, Mass. — Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., […]
Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that it has been selected to provide tertiary analysis for whole genome sequencing services for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in Hong Kong. The HKGP, being […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
